耐甲氧西林金黄色葡萄球菌菌血症和心内膜炎治疗的成本效益分析是一个难题。 - Suppr | 超能文献

Cost-effectiveness analysis of treatment of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis is a difficult issue.

作者信息

Westling Katarina

出版信息

Clin Infect Dis. 2009 Sep 1;49(5):699-701. doi: 10.1086/604711.

DOI:10.1086/604711

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Cost-effectiveness analysis of treatment of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis is a difficult issue.耐甲氧西林金黄色葡萄球菌菌血症和心内膜炎治疗的成本效益分析是一个难题。

Clin Infect Dis. 2009 Sep 1;49(5):699-701. doi: 10.1086/604711.

2

Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.达托霉素与万古霉素及庆大霉素治疗耐甲氧西林金黄色葡萄球菌菌血症和/或心内膜炎患者的成本效益

Clin Infect Dis. 2009 Sep 1;49(5):691-8. doi: 10.1086/604710.

3

Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.用替拉万星成功治疗耐甲氧西林金黄色葡萄球菌心内膜炎。

J Antimicrob Chemother. 2010 Jun;65(6):1315-6. doi: 10.1093/jac/dkq113. Epub 2010 Apr 7.

4

Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis.万古霉素暴露史与耐甲氧西林金黄色葡萄球菌相关复杂性菌血症和感染性心内膜炎患者的结局和成本。

Clin Ther. 2011 Oct;33(10):1475-82. doi: 10.1016/j.clinthera.2011.08.011. Epub 2011 Sep 16.

5

Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.一名耐甲氧西林金黄色葡萄球菌心内膜炎的肝移植受者在利奈唑胺和万古霉素治疗失败后，使用达托霉素成功进行挽救治疗。

Transpl Infect Dis. 2009 Aug;11(4):346-8. doi: 10.1111/j.1399-3062.2009.00403.x. Epub 2009 May 21.

6

[Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].[耐甲氧西林金黄色葡萄球菌所致菌血症和心内膜炎治疗的共识文件。西班牙传染病与临床微生物学会]

Enferm Infecc Microbiol Clin. 2009 Feb;27(2):105-15. doi: 10.1016/j.eimc.2008.09.003. Epub 2009 Feb 11.

7

Staphylococcus aureus bacteremia: epidemiology, pathophysiology, and management strategies.金黄色葡萄球菌菌血症：流行病学、病理生理学及管理策略

Clin Infect Dis. 2009 May 15;48 Suppl 4:S231-7. doi: 10.1086/598189.

8

Serious infections caused by methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌引起的严重感染。

Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S183-97. doi: 10.1086/653519.

9

Lack of increase in time to blood culture positivity in a patient with persistent methicillin-resistant Staphylococcus aureus bacteremia predicts failure of antimicrobial therapy.对于持续存在耐甲氧西林金黄色葡萄球菌菌血症的患者，血培养阳性时间未延长预示抗菌治疗失败。

J Microbiol Immunol Infect. 2008 Aug;41(4):355-7.

10

[Pharmacoeconomic analysis of the treatment of methicillin-resistant Staphylococcus aureus with daptomycin or vancomycin].[达托霉素或万古霉素治疗耐甲氧西林金黄色葡萄球菌的药物经济学分析]

Rev Esp Quimioter. 2012 Dec;25(4):283-92.

引用本文的文献

1

IsaB Inhibits Autophagic Flux to Promote Host Transmission of Methicillin-Resistant Staphylococcus aureus.IsaB抑制自噬通量以促进耐甲氧西林金黄色葡萄球菌的宿主传播。

J Invest Dermatol. 2015 Nov;135(11):2714-2722. doi: 10.1038/jid.2015.254. Epub 2015 Jul 2.